US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Aziyo Biologics Inc (AZYO)
Aziyo Biologics Inc (AZYO) ニュース

AZYO

Aziyo Biologics (AZYO)

Aziyo Biologics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AZYO

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/04/23	05 : 33	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:AZYO	Aziyo Biologics Inc
2024/04/23	05 : 30	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:AZYO	Aziyo Biologics Inc
2024/04/02	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AZYO	Aziyo Biologics Inc
2023/09/08	21 : 30	GlobeNewswire Inc.	Elutia to Present at the H.C. Wainwright 25th Annual Global Investment Conference	NASDAQ:AZYO	Aziyo Biologics Inc
2023/09/07	21 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AZYO	Aziyo Biologics Inc
2023/09/07	05 : 05	GlobeNewswire Inc.	Aziyo Biologics Rebrands as Elutia to Reflect Strategic Focus on Drug Eluting Biomatrices	NASDAQ:AZYO	Aziyo Biologics Inc
2023/08/30	21 : 30	GlobeNewswire Inc.	Aziyo Biologics Announces Publication of a CanGaroo® Case Study Demonstrating Bioenvelope Benefits for Reoperative Procedures	NASDAQ:AZYO	Aziyo Biologics Inc
2023/08/15	06 : 00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:AZYO	Aziyo Biologics Inc
2023/08/15	05 : 24	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AZYO	Aziyo Biologics Inc
2023/08/15	05 : 05	GlobeNewswire Inc.	Aziyo Biologics Reports Second Quarter 2023 Financial Results - Transformation Continues to Drug-Eluting Biomatrix Company	NASDAQ:AZYO	Aziyo Biologics Inc
2023/08/01	05 : 05	GlobeNewswire Inc.	Aziyo Biologics to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023	NASDAQ:AZYO	Aziyo Biologics Inc
2023/07/18	05 : 05	PR Newswire (US)	SWK Holdings Highlights Recent Achievements and Provides Portfolio Update	NASDAQ:AZYO	Aziyo Biologics Inc
2023/07/14	06 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AZYO	Aziyo Biologics Inc
2023/07/14	05 : 30	GlobeNewswire Inc.	Aziyo Biologics Announces Voluntary Recall of Viable Bone Matrix Products	NASDAQ:AZYO	Aziyo Biologics Inc
2023/06/24	00 : 31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AZYO	Aziyo Biologics Inc
2023/06/13	00 : 32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AZYO	Aziyo Biologics Inc
2023/06/10	05 : 32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AZYO	Aziyo Biologics Inc
2023/05/19	21 : 15	GlobeNewswire Inc.	Aziyo Biologics Presents Positive Clinical Data on CanGaroo® Biologic Envelope	NASDAQ:AZYO	Aziyo Biologics Inc
2023/05/13	06 : 16	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:AZYO	Aziyo Biologics Inc
2023/05/11	05 : 05	GlobeNewswire Inc.	Aziyo Biologics Reports Highest Sales and Gross Profit in Company History	NASDAQ:AZYO	Aziyo Biologics Inc
2023/05/04	05 : 05	GlobeNewswire Inc.	Aziyo Biologics to Report First Quarter 2023 Financial Results on Wednesday, May 10, 2023	NASDAQ:AZYO	Aziyo Biologics Inc
2023/04/21	05 : 30	GlobeNewswire Inc.	Aziyo Biologics and LeMaitre Vascular Partner for the Distribution of Aziyo’s Cardiovascular Portfolio	NASDAQ:AZYO	Aziyo Biologics Inc
2023/04/07	19 : 01	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:AZYO	Aziyo Biologics Inc
2023/03/24	06 : 10	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:AZYO	Aziyo Biologics Inc
2023/03/23	05 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AZYO	Aziyo Biologics Inc
2023/03/23	05 : 01	GlobeNewswire Inc.	Aziyo Biologics Reports Record Full Year 2022 Revenues	NASDAQ:AZYO	Aziyo Biologics Inc
2023/03/22	21 : 30	GlobeNewswire Inc.	Aziyo Biologics and Sientra Announce SimpliDerm® Partnership to Improve Women’s Access to Biologics for Soft Tissue Reconstruction	NASDAQ:AZYO	Aziyo Biologics Inc
2023/03/21	06 : 27	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AZYO	Aziyo Biologics Inc
2023/03/20	21 : 00	GlobeNewswire Inc.	Aziyo Biologics Provides Update on FDA Submission for CanGaroo® RM Antibacterial Envelope	NASDAQ:AZYO	Aziyo Biologics Inc
2023/03/16	05 : 05	GlobeNewswire Inc.	Aziyo Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on Wednesday, March 22, 2023	NASDAQ:AZYO	Aziyo Biologics Inc

Showing the most relevant articles for your search:NASDAQ:AZYO

1 2 3 4 5 6 次へ >>

Intesa Sanpaolo

DAXplus Minimum Variance...

Tmt Acquisition

Sonomax Technologies (CE)

Almonty Industries

Orbit Garant Drilling

Ivz Msci Wd Esg

In Systcom (CE)

RSE Archive (GM)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約